TransMedics (TMDX) Director David Weill Buys 1,336 Shares

What Happened
David Weill, a director of TransMedics Group, Inc. (TMDX), purchased 1,336 shares in an open-market transaction on September 11, 2026. The shares were acquired at $81.63 per share for a total transaction value of $109,058. This was a purchase (insider buying) rather than a sale.

Key Details

• Transaction date: 2026-09-11
• Transaction type: Open-market purchase (Code P)
• Price per share: $81.63
• Shares purchased: 1,336
• Total value: $109,058 (approx.)
• Form filed: 2026-09-14 (filing appears timely based on provided dates)
• Shares owned after transaction: Not disclosed in the information provided
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other footnotes were noted in the provided details

Context
Insider purchases can be interpreted by investors as a signal of confidence, but they are one data point among many and do not guarantee future performance. This filing simply reports the purchase; it does not explain the insider’s motivation.